Drug Research
Exscientia enters $70M collaboration to develop anti-viral therapeutics against Coronavirus and other viruses with pandemic potential
Exscientia, an AI-driven pharmatech company with a mission to radically improve how drugs are discovered, announced a four-year collaboration with the Bill & Melinda...
Drug Research
EnGeneIC develops world-first nanocellular anti-COVID-19 vaccine that defeats mutant viruses and stimulates a broad anti-viral response
EnGeneIC Limited, an Australian, Sydney-based biotechnology company, has developed a globally unique nanocellular technology that in pre-clinical animal studies has been shown to stimulate...
Drug Research
NeuExcell and Spark partner to develop gene therapy for Huntingtons Disease
NeuExcell Therapeutics and Spark Therapeutics, a member of the Roche Group announced a gene therapy collaboration aimed at developing a safe and effective treatment...
Drug Research
Takeda to Manufacture and Provide 150 Million Doses of Novavax COVID-19 Vaccine Candidate to the Government of Japan
Takeda Pharmaceutical Company Limited announced that the Government of Japan’s Ministry of Health, Labour and Welfare (MHLW) will purchase 150 million doses of Novavax’...
News
Berrys Vistop Meets Growing Sustainability and Sterilization Demands
Following the International Sustainability and Carbon Certificate (ISCC) Plus accreditation of its Berry Astra Plastique facility in Saint-Georges-de-Reneins, France, Berry Healthcare’s market-leading Vistop® PP36...
News
Genezen Appoints New CEO as GMP Expansion Begins
Genezen Inc., a cell and gene therapy Contract Development and Manufacturing Organization (CDMO), has appointed Ray Kaczmarek as CEO.
Mr. Kaczmarek has over 28 years...
News
CEVEC and UCB sign agreement for the use of CEVEC’S ELEVECTA AAV manufacturing technology in Gene Therapy
CEVEC Pharmaceuticals GmbH announced the signing of an agreement with UCB S.A. on the evaluation and use of CEVEC’s proprietary ELEVECTA® Technology for the...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read